Methylphenidate treatment	placebo	reduction of the risk for relapse to substance use in criminal offenders	1222	1513	The MPH-treated group reduced their ADHD symptoms during the trial (P = 0.011) and had a significantly higher proportion of drug-negative urines compared with the placebo group (P = 0.047), including more amphetamine-negative urines (P = 0.019) and better retention to treatment (P = 0.032).
Methylphenidate treatment	placebo	reduction of the risk for relapse to substance use in criminal offenders	603	669	Participants were recruited from medium security prisons in Sweden
Methylphenidate treatment	placebo	reduction of the risk for relapse to substance use in criminal offenders	1537	1756	Methylphenidate treatment reduces attention deficit hyperactivity disorder symptoms and the risk for relapse to substance use in criminal offenders with attention deficit hyperactivity disorder and substance dependence.
